Risk factors of catheter- associated bloodstream infection: Systematic review and meta-analysis.
Lafuente Cabrero E, Terradas Robledo R, Civit Cuñado A, García Sardelli D, Hidalgo López C, Giro Formatger D, Lacueva Perez L, Esquinas López C, Tortosa Moreno A.
PLoS One. 2023 Mar 23;18(3):e0282290. doi: 10.1371/journal.pone.0282290. eCollection 2023.
A Meta-Analysis of Incidence of Catheter-Related Bloodstream Infection with Midline Catheters and Peripherally Inserted Central Catheters.
Chen X, Liang M.
J Healthc Eng. 2022 Mar 12;2022:6383777. doi: 10.1155/2022/6383777. eCollection 2022.
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD.
Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12.
The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Colombel JF, Sands BE, Rutgeerts P, Sandborn W, Danese S, D'Haens G, Panaccione R, Loftus EV Jr, Sankoh S, Fox I, Parikh A, Milch C, Abhyankar B, Feagan BG.
Gut. 2017 May;66(5):839-851. doi: 10.1136/gutjnl-2015-311079. Epub 2016 Feb 18.
Catheter-related and infusion-related sepsis.
Kumar A, Kethireddy S, Darovic GO.
Crit Care Clin. 2013 Oct;29(4):989-1015. doi: 10.1016/j.ccc.2013.07.002.
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG, Kavirayani A.
Eur J Haematol. 2023 Sep;111(3):458-476. doi: 10.1111/ejh.14029. Epub 2023 Jun 21.
Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
Keller SC, Hannum SM, Weems K, Oladapo-Shittu O, Salinas AB, Marsteller JA, Gurses AP, Klein EY, Shpitser I, Crnich CJ, Bhanot N, Rock C, Cosgrove SE; Home Infusion CLABSI Prevention Collaborative.
Infect Control Hosp Epidemiol. 2023 Nov;44(11):1748-1759. doi: 10.1017/ice.2023.70. Epub 2023 Apr 20.
Risk of catheter-related bloodstream infection associated with midline catheters compared with peripherally inserted central catheters: A meta-analysis.
Lu H, Hou Y, Chen J, Guo Y, Lang L, Zheng X, Xin X, Lv Y, Yang Q.
Nurs Open. 2021 May;8(3):1292-1300. doi: 10.1002/nop2.746. Epub 2020 Dec 29.
The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.
Martin L, Derwall M, Al Zoubi S, Zechendorf E, Reuter DA, Thiemermann C, Schuerholz T.
Chest. 2019 Feb;155(2):427-437. doi: 10.1016/j.chest.2018.08.1037. Epub 2018 Aug 29.
Update: Catheter-related bloodstream infection rates in relation to clinical practice and needleless device type.
Blake M.
Can J Infect Control. 2008 Fall;23(3):156-60, 162.
